Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 2/20 | 0.50 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.48 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.48 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.44 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.37 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5283667 | 0.97 | GNAI3 (0.52) | BBOX1GNAI3GNAO1GNAI1LMNA | |
| SCHEMBL10256900 | 0.97 | BBOX1 (0.48) | BBOX1GNAI3GNAO1GNAI1LMNA | |
| SCHEMBL5307532 | 0.97 | GNAI3 (0.52) | BBOX1GNAI3GNAO1GNAI1LMNA | |
| SCHEMBL372263 | 0.97 | GNAI3 (0.52) | BBOX1GNAI3GNAO1GNAI1LMNA | |
| SCHEMBL5284113 | 0.97 | GNAI3 (0.52) | BBOX1GNAI3GNAO1GNAI1LMNA | |
| SCHEMBL5297910 | 0.97 | GNAI3 (0.52) | BBOX1GNAI3GNAO1GNAI1LMNA | |
| SCHEMBL372617 | 0.97 | BBOX1 (0.48) | BBOX1GNAI3GNAO1GNAI1LMNA | |
| SCHEMBL899013 | 0.97 | GNAI3 (0.52) | BBOX1GNAI3GNAO1GNAI1LMNA | |
| SCHEMBL372381 | 0.97 | GNAI3 (0.52) | BBOX1GNAI3GNAO1GNAI1LMNA | |
| SCHEMBL3771595 | 0.97 | GNAI3 (0.52) | BBOX1GNAI3GNAO1GNAI1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 559 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122085568-A | Ion gel electrolyte composition capable of being subjected to room-temperature in-situ spontaneous polymerization, electrolyte and application | — | 2026-05-26 | — | — | CN | claimed |
| US-12620595-B2 | Increased capacity battery cell using reservoir replenishing additives | SOUTH 8 TECHNOLOGIES, INC. (US) | 2026-05-05 | — | — | US | claimed |
| US-20260051512-A1 | Increased Capacity Battery Cell Using Reservoir Replenishing Additives | SOUTH 8 TECH INC (US) | 2026-02-19 | — | — | US | claimed |
| WO-2025230533-A1 | APPARATUS AND METHOD OF LIQUEFIED GAS ELECTROLYTE PREPARATION | SOUTH 8 TECHNOLOGIES, INC. (US) | 2025-11-06 | — | — | WO | claimed |
| US-20250113829-A1 | HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS | nanoSUR LLC | 2025-04-10 | — | — | US | claimed |
| CN-111356650-B | Method for manufacturing vertically aligned carbon nanotubes and electrochemical capacitor using these nanotubes as electrode | 纳瓦科技公司 | 2024-07-05 | — | — | CN | claimed |
| WO-2024138122-A1 | LITHIUM-METAL RECHARGEABLE ELECTROCHEMICAL CELLS WITH LIQUID ELECTROLYTES AND SINGLE-CRYSTAL NICKEL-MANGANESE-COBALT | Cuberg, Inc. (US) | 2024-06-27 | — | — | WO | claimed |
| US-20240213540-A1 | LITHIUM-METAL RECHARGEABLE ELECTROCHEMICAL CELLS WITH LIQUID ELECTROLYTES AND SINGLE-CRYSTAL NICKEL-MANGANESE-COBALT | Cuberg, Inc. (US) | 2024-06-27 | — | — | US | claimed |
| US-20240120543-A1 | CHEMICALLY INERT ADDITIVES FOR ELECTROCHEMICAL CELLS | SOUTH 8 TECH INC (US) | 2024-04-11 | — | — | US | claimed |
| EP-3676221-B1 | METHOD FOR MANUFACTURING VERTICALLY ALIGNED CARBON NANOTUBES, AND ELECTROCHEMICAL CAPACITORS USING THESE NANOTUBES AS ELECTRODES | NAWATECHNOLOGIES (FR) | 2024-04-10 | — | — | EP | claimed |
| US-20090242414-A1 | ELECTRONCHEMICAL DEPOSITION OF TANTALUM AND/OR COPPER IN IONIC LIQUIDS | MERCK PATENT GMBH (DE) | 2009-10-01 | — | — | US | claimed |
| EP-1951934-B1 | ELECTROCHEMICAL DEPOSITION OF SELENIUM IN IONIC LIQUIDS | MERCK PATENT GMBH (DE) | 2009-08-19 | — | — | EP | claimed |
| US-7449169-B2 | Useful as a catalyst in hydrocarbon cracking reactions, alkane isomerization, dewaxing and isodewaxing of paraffins, catalysts for separation and transformation processes of organic compounds; providing high yields of light olefins with a high octane-barrel number of the gasoline produced | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2008-11-11 | — | — | US | claimed |
| US-20080210566-A1 | Electrochemical Deposition of Selenium in Ionic Liquids | MERCK PATENT GESELLSCHAFT (DE) | 2008-09-04 | — | — | US | claimed |
| EP-1951934-A1 | ELECTROCHEMICAL DEPOSITION OF SELENIUM IN IONIC LIQUIDS | Merck Patent GmbH (DE) | 2008-08-06 | — | — | EP | claimed |
| EP-1831433-A2 | ELECTROCHEMICAL DEPOSITION OF TANTALUM AND/OR COPPER IN IONIC LIQUIDS | Merck Patent GmbH (DE) | 2007-09-12 | — | — | EP | claimed |
| WO-2007039035-A1 | ELECTROCHEMICAL DEPOSITION OF SELENIUM IN IONIC LIQUIDS | MERCK PATENT GMBH (DE) | 2007-04-12 | — | — | WO | claimed |
| WO-2006061081-A2 | ELECTROCHEMICAL DEPOSITION OF TANTALUM AND/OR COPPER IN IONIC LIQUIDS | MERCK PATENT GMBH (DE) | 2006-06-15 | — | — | WO | claimed |
| US-20050182278-A1 | Microporous crystalline zeolite material (zeolite ITQ-22), synthesis method thereof and use of same as a catalyst | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2005-08-18 | — | — | US | claimed |
| EP-1514844-A1 | MICROPOROUS CRYSTALLINE ZEOLITE MATERIAL (ZEOLITE ITQ-22), SYNTHESIS METHOD THEREOF AND USE OF SAME AS A CATALYST | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2005-03-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250113829-A1 | HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS | NSUN2, NSUN3, RNGTT | BBOX1 1898/4885GNAI3 3859/4885GNAO1 2878/4885 |
| US-12620595-B2 | Increased capacity battery cell using reservoir replenishing additives | SLC9A2, SLC8A1, CA2 | BBOX1 3990/4885GNAI3 2913/4885GNAO1 1295/4885 |
| US-20260051512-A1 | Increased Capacity Battery Cell Using Reservoir Replenishing Additives | SCO2, CA2, SLC9A2 | BBOX1 3415/4885GNAI3 2016/4885GNAO1 1646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.